"Urinary Excretion of Steroid Metabolites after Chronic Androstenedione" by Gregory A. Brown, Matthew D. Vukovich et al.
 

Urinary Excretion of Steroid Metabolites after Chronic Androstenedione Ingestion

Document Type

Article

Publication Date

12-2004

Abstract

Urinary steroid excretion after androstenedione intake has been examined after a single dose of 50 mg and single doses of 100 or 300 mg/d for 7 d. We evaluated the effects of 28 d of 100 mg three times a day (t.i.d.) androstenedione intake on urinary steroid excretion. Twenty healthy men, ages 30–39 yr (33.5 ± 0.6), consumed 100 mg androstenedione t.i.d. or placebo for 28 d. Urine samples were analyzed for testosterone, epitestosterone, androsterone, and etiocholanolone via HPLC/tandem mass spectrometry on d 0 and 28. Androstenedione intake increased (P < 0.05) urinary testosterone 35.1 ± 10.5 ng/ml vs. 251.6 ± 87.5 ng/ml, epitestosterone 35.3 ± 8.8 ng/ml vs. 99.7 ± 28.7 ng/ml, androsterone 2,102 ± 383 ng/ml vs. 15,767 ± 3,358 ng/ml, and etiocholanolone 1,698 ± 409 ng/ml vs. 11,329 ± 2,656 ng/ml (means ± SE). Although the testosterone to epitestosterone ratio (T/E) tended to increase with androstenedione intake (1.2 ± 0.3 vs. 4.0 ± 1.6; P = 0.12), only one subject had a urinary T/E greater than the current Olympic criteria (>6.0) for a positive drug test. Chronic intake of 100 mg androstenedione t.i.d. increases the urinary excretion of steroid metabolites. Due to inconsistent increases in the T/E ratio, the T/E ratio may not effectively detect androstenedione use.

Publication Title

The Journal of Clinical Endocrinology & Metabolism

Volume

89

Issue

12

First Page

6235

DOI of Published Version

10.1210/jc.2003-031743

Share

COinS